GCM
ACH

Gladius Capital Management’s Accendra Health ACH Stock Holding History

Gladius Capital Management’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,791
Closed -$57K – 468
2022
Q2 		$57K Buy
+1,791
New +$64.9K ﹤0.01% 241

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gladius Capital Management's ACH Position: Q3 2022 in Review

Gladius Capital Management sold out of Accendra Health (ACH) in Q3 2022, closing a stake of 1,791 shares — an estimated $57K sold.

Gladius Capital Management first reported a position in ACH in Q2 2022 and held it in 1 quarter. The position peaked at $57K in Q2 2022. 227 funds tracked by Wall St. Rank hold ACH as of Q3 2022.

  • Gladius Capital Management reported no remaining Accendra Health position as of Q3 2022 after selling out during the quarter.
  • Gladius Capital Management sold 1,791 Accendra Health shares in Q3 2022, an estimated $57K.
  • Gladius Capital Management first reported a position in Accendra Health in Q2 2022 and held it in 1 quarter.
  • Gladius Capital Management's Accendra Health position peaked at $57K in Q2 2022.
  • 227 funds tracked by Wall St. Rank held Accendra Health as of Q3 2022.

Based on Gladius Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.